首页> Clinical biochemistry> Improving the translation of novel biomarkers to clinical practice: The story of cystatin C implementation in Canada: A professional practice column.

Improving the translation of novel biomarkers to clinical practice: The story of cystatin C implementation in Canada: A professional practice column.

导出原文传递

翻译打印收藏纠错

第一作者： Ola Z,Ismail

第一单位： Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario N5A 5A5, Canada.

作者： Ola Z,Ismail ^[1] ; Vipin,Bhayana ^[1] ; Michael,Kadour ^[1] ; Nathalie,Lepage ^[2] ; Manjula,Gowrishankar ^[3] ; Guido,Filler ^[4]

作者单位： Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario N5A 5A5, Canada. ^[1] Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario K1H 8L1, Canada. ^[2] Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. ^[3] Department of Pathology and Laboratory Medicine, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario N5A 5A5, Canada; Department of Pediatrics, Schulich School of Medicine & Dentistry, London, ON N6A 5W9, Canada; Department of Medicine, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario N5A 5A5, Canada. Electronic address: guido.filler@lhsc.on.ca. ^[4]

医学主题词加拿大(Canada);半胱氨酸蛋白酶抑制物C(Cystatin C);人类(Humans);肾功能试验(Kidney Function Tests);专业业务(Professional Practice)

DOI 10.1016/j.clinbiochem.2017.01.005

PMID 28088453

发布时间 2018-05-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交